Browse > Article
http://dx.doi.org/10.4040/jkan.2012.42.5.644

A Meta-analysis of Chemotherapy related Cognitive Impairment in Patients with Breast Cancer  

Park, Jin-Hee (College of Nursing, Ajou University)
Bae, Sun Hyoung (College of Nursing, Yonsei University)
Publication Information
Journal of Korean Academy of Nursing / v.42, no.5, 2012 , pp. 644-658 More about this Journal
Abstract
Purpose: The purpose of this study was to evaluate the cognitive effects of chemotherapy in patients with breast cancer. Methods: Using several databases, prospective studies were collected up to August 2011. Of 2,106 publications identified, 12 met the inclusion criteria, and 8 studies were used to estimate the effect size of chemotherapy on cognitive impairment. Results: Twelve studies were done since 2005 and most of the research was performed in Europe or North America. Eight studies were used to generate effect size across the cognitive domains of attention/concentration, verbal and visual memory, executive function, visuospatial skill, language, and subjective cognitive function. Each of the cognitive domains showed small effect sizes (-0.02 ~ -0.26), indicating diminished cognitive function for the chemotherapy group compared with non-chemotherapy groups. Conclusion: Finding suggests that breast cancer patients who undergo chemotherapy may experience mild cognitive decline. Further study is needed to generate knowledge and guideline for interventions to address chemotherapy related cognitive impairment in these patients.
Keywords
Chemotherapy; Mild cognitive impairment; Attention; Memory; Breast neoplasms;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 0  (Related Records In Web of Science)
연도 인용수 순위
1 Nelson, C. J., Nandy, N., & Roth, A. J. (2007). Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions. Palliative and Supportive Care, 5, 273-280. http://dx.doi.org/10.1017/S1478951507000442
2 Noal, S., Levy, C., Hardouin, A., Rieux, C., Heutte, N., Segura, C., et al. (2011). One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 81, 795-803. http://dx.doi.org/10.1016/j.ijrobp.2010.06.037   DOI
3 Ouimet, L. A., Stewart, A., Collins, B., Schindler, D., & Bielajew, C. (2009). Measuring neuropsychological change following breast cancer treatment: An analysis of statistical models. Journal of Clinical and Experimental Neuropsychology, 31, 73-89. http://dx.doi.org/10.1080/13803390801992725   DOI
4 Quesnel, C., Savard, J., & Ivers, H. (2009). Cognitive impairments associated with breast cancer treatments: Results from a longitudinal study. Breast Cancer Research and Treatment, 116, 113-123. http://dx.doi.org/10.1007/s10549-008-0114-2   DOI
5 Isaki, E., Spaulding, T. J., & Plante, E. (2008). Contributions of language and memory demands to verbal memory performance in language-learning disabilities. Journal of Communication Disorders, 41, 512-530. http://dx.doi.org/10.1016/j.jcomdis.2008.03.006   DOI
6 Jansen, C. E., Miaskowski, C. A., Dodd, M. J., & Dowling, G. A. (2007). A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncology Nursing Forum, 34, 997-1005. http://dx.doi.org/10.1188/07.ONF.997-1005   DOI
7 Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., et al. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430. http://dx.doi.org/10.1002/pon.964   DOI
8 Rosenthal, R. (1991). Meta-analytic procedures for social research. Newbury Park, CA: Sage Publications.
9 Scottish Intercollegiate Guidelines Network. (2011). SIGN 50: A guideline developer's handbook. Retrieved January, 11, 2012, from http://www.sign.ac.uk/pdf/sign50.pdf
10 Braver, T. S., & Barch, D. M. (2002). A theory of cognitive control, aging cognition, and neuromodulation. Neuroscience and Biobehavioral Reviews, 26, 809-817. http://dx.doi.org/10.1016/S0149-7634(02)00067-2   DOI
11 Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009). Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology, 18, 134-143. http://dx.doi.org/10.1002/pon.1379   DOI
12 Cusimano, A. (2001). Learning disabilities: There is a cure. Pennsylvania, PA: Achieve Publications.
13 Debess, J., Riis, J. O., Engebjerg, M. C., & Ewertz, M. (2010). Cognitive function after adjuvant treatment for early breast cancer: A population-based longitudinal study. Breast Cancer Research and Treatment, 121, 91-100. http://dx.doi.org/10.1007/s10549-010-0756-8   DOI
14 DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-188. http://dx.doi.org/10.1016/0197-2456(86)90046-2   DOI
15 Egger, M., Davey Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315, 629-634. http://dx.doi.org/10.1136/bmj.315.7109.629   DOI
16 Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K. A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59, 60-70. http://dx.doi.org/10.1016/j.bandc.2005.05.001   DOI
17 Fan, H. G., Houede-Tchen, N., Yi, Q. L., Chemerynsky, I., Downie, F. P., Sabate, K., et al. (2005). Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1-and 2-year follow-up of a prospective controlled study. Journal of Clinical Oncology, 23, 8025-8032. http://dx.doi.org/10.1200/JCO.2005.01.6550   DOI
18 Kim, G. D., Chung, B. Y., Kim, K. H., Byun, H. S., & Choi, E. H. (2011). Analysis of a trend of instrument usage to assess cognitive function of breast cancer patients undergoing chemotherapy. Journal of Korean Oncology Nursing, 11, 179-185. http://dx.doi.org/10.5388/jkon.2011.11.3.179   DOI
19 Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. The Clinical Neuropsychologist, 20, 76-89. http://dx.doi.org/10.1080/138540491005875   DOI
20 Tager, F. A., McKinley, P. S., Schnabel, F. R., El-Tamer, M., Cheung, Y. K., Fang, Y., et al. (2010). The cognitive effects of chemotherapy in post-menopausal breast cancer patients: A controlled longitudinal study. Breast cancer Research and Treatment, 123, 25-34. http://dx.doi.org/10.1007/s10549-009-0606-8
21 Knobf, M. T. (2011). Clinical update: Psychosocial responses in breast cancer survivors. Seminars in Oncology Nursing, 27, e1-e14. http://dx.doi.org/10.1016/j.soncn.2011.05.001
22 Korean National Statistical Office. (2009). Annual report on cause of death statistics. Seoul: Author.
23 Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment (4th ed.). New York, NY: Oxford University Press.
24 Matsuda, T., Takayama, T., Tashiro, M., Nakamura, Y., Ohashi, Y., & Shimozuma, K. (2005). Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer, 12, 279-287. http://dx.doi.org/10.2325/jbcs.12.279   DOI
25 Myers, J. S. (2009). Chemotherapy-related cognitive impairment. Clinical Journal of Oncology Nursing, 13, 413-421. http://dx.doi.org/10.1188/09.CJON.413-421   DOI
26 National Evidence-based Healthcare Collaborating Agency. (2011). NECA's guidance for systematic review for new health technology assessment. Seoul: Author.
27 Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., et al. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal of Clinical Oncology, 28, 4434-4440. http://dx.doi.org/10.1200/JCO.2009.27.0827   DOI
28 Gazzaniga, M. S., Ivry, R. B., & Mangun, G. R. (2002). Cognitive neuroscience: The biology of the mind (2nd ed.). New York, NY: W.W. Norton & Company.
29 Glogoski, C., Milligan, N. V., & Wheatley, C. J. (2006). Evaluation and treatment of cognitive dysfunction. In H. M. Pendleton & W. Schultz-Krohn (Eds.), Pedretti's occupational therapy: Practice skills for physical dysfunction (6th ed.)(pp. 589-608). St. Louis, MO: Mosby Elsevier.
30 Ahles, T. A., & Saykin, A. J. (2002). Breast cancer chemotherapy-related cognitive dysfunction. Clinical Breast Cancer, 3(Suppl 3), S84-S90. http://dx.doi.org/10.3816/CBC.2002.s.018   DOI